Kripalani K J, McKinstry D N, Singhvi S M, Willard D A, Vukovich R A, Migdalof B H
Clin Pharmacol Ther. 1980 May;27(5):636-41. doi: 10.1038/clpt.1980.90.
The disposition of captopril, an angiotensin-converting enzyme inhibitor with antihypertensive properties, was studied in 10 normal male subjects after a single 100-mg tablet of 35S-labeled drug. Average absorption parameters for unchanged captopril in blood were Tmax 0.93 +/- 0.08 hr and Cmax 800 +/- 76 ng/ml. For total radioactivity in blood the values were Tmax 1.05 +/- 0.08 hr and Cmax 1,580 +/- 90 ng/ml (as captopril equivalents). Because of the curvilinearity of the semilogarithmic plots of blood concentrations of captopril:time, elimination half-life (t1/2) of unchanged drug could not be determined. At 1 hr unchanged captopril accounted for about 52% of total radioactivity in blood, and the dimeric disulfide metabolite of captopril accounted for about 10%. In the first 5 days after dosing, an average of about 68% of the radioactive dose was recovered in urine and 18% in feces. The distribution of radioactivity in the first 24-hr urine sample (66% of the dose) was 58% captopril (38% of dose), 2% captopril disulfide (1.5% of dose), and 40% unidentified polar metabolites (26% of dose).
对10名正常男性受试者口服一片100毫克的35S标记的具有抗高血压特性的血管紧张素转换酶抑制剂卡托普利后的情况进行了研究。血液中未变化的卡托普利的平均吸收参数为:达峰时间(Tmax)0.93±0.08小时,峰浓度(Cmax)800±76纳克/毫升。血液中总放射性的相应值为:Tmax 1.05±0.08小时,Cmax 1580±90纳克/毫升(以卡托普利当量计)。由于卡托普利血药浓度-时间半对数图呈曲线状,无法确定未变化药物的消除半衰期(t1/2)。给药1小时时,未变化的卡托普利约占血液中总放射性的52%,卡托普利的二聚体二硫化物代谢产物约占10%。给药后的前5天,平均约68%的放射性剂量经尿液回收,18%经粪便回收。给药后第一个24小时尿液样本(占剂量的66%)中的放射性分布为:58%为卡托普利(占剂量的38%),2%为卡托普利二硫化物(占剂量的1.5%),40%为未鉴定的极性代谢产物(占剂量的26%)。